Replicor Inc.

Canada

 
Total IP 29
Total IP Rank # 49,919
IP Activity Score 1.4/5.0    5
IP Activity Rank # 195,948

Patents

Trademarks

10 0
7 0
12 0
0
 
Last Patent 2023 - Methods and compositions for the...
First Patent 2003 - Non-sequence complementary antiv...

Latest Inventions, Goods, Services

2021 Invention Methods and compositions for the inhibition of hepatitis b and hepatitis d virus infections. The...
Invention Methods and compositions for the inhibition of hepatitis b and hepatitis d virus infections. The ...
2015 Invention Methods for the treatment of hepatitis b and hepatitis d infections. It is disclosed a method for...
Invention Methods for the treatment of hepatitis b and hepatitis d virus infections. It is disclosed a meth...
2013 Invention Oligonucleotide chelate complexes. The present disclosure describes the broadly active chelation ...
Invention Oligonucleotide chelate complex methods. It is described pharmaceutical compositions and methods ...
Invention Oligonucleotide chelate complex-polypeptide compositions and methods. It is disclosed a pharmaceu...
Invention Oligonucleotide chelate complex—polypeptide compositions and methods. It is disclosed a pharmaceu...
2011 Invention Methods for inhibition of apolipoprotein h. The present disclosure relates to methods for ...
2009 Invention Antiviral oligonucleotides targeting rsv. Random sequence oligonucleotides that have antiviral a...
Invention Antiviral oligonucleotides targeting viral families. Random sequence oligonucleotides that have ...
2008 Invention Antiviral oligonucleotides targeting hbv. Random sequence oligonucleotides that have antiviral ac...
Invention Antiviral oligonucleotides targeting viral families. Random sequence oligonucleotides that have a...
Invention Antiviral oligonucleotides. Random sequence oligonucleotides that have antiviral activity are des...
2006 Invention Anti-inflammatory molecules and their uses. The invention relates to oligonucleotides acting pred...
Invention Therapeutic molecules and their uses. The present invention relates with the identification...
Invention Therapeutic molecules and their uses. The present invention relates with the identification and u...
Invention Antimicrobial molecules and their uses. The present invention relates with the identification and...
Invention Anti-ocular angiogenesis molecules and their uses. The invention relates to oligonucleotides inhi...
Invention Oligonucleotides inhibiting cell proliferation. The present invention is concerned with the ident...
Invention Anti amyloid-related disease molecules and their uses. Oligonucleotides formulation comprising ol...
Invention Sulfur oligonucleotides having antiviral activities. Sulfur oligonucleotides having antiviral act...
2005 Invention Antiviral oligonucleotides. Random sequence oligonucleotides that have antiviral activity are de...
Invention Antiviral oligonucleotides. Random sequence oligonucleotides that have antiviral activity a...
Invention Oligonucleotides targeting prion diseases and uses. Oligonucleotide compounds active against prio...
Invention Method for inhibiting cellular proliferation. The present invention relates to a method and compo...
2004 Invention Oligonucleotides targeting prion diseases. Randomer phosphorothioate oligonucleotide composition...
Invention Oligonucleotides targeting prion diseases. Randomer phosphorothioate oligonucleotide compos...
Invention Oligonucleotides targeting prion diseases. Randomer phosphorothioate oligonucleotide compositions...
2003 Invention Antiviral oligonucleotides targeting rsv. Random sequence oligonucleotides that have antiviral ac...
Invention Antiviral oligonucleotides targeting hiv. Random sequence oligonucleotides that have antiviral ac...